Progenika Biopharma Overview
- Founded
- 2000
- Status
- Acquired/Merged
- Latest Deal Type
- Corporate
- Financing Rounds
- 3
- Investments
- 3
Progenika Biopharma General Information
Description
Operator of a biotechnology company in Spain. The company is engaged in the development, production and commercialization of tools for the diagnosis and prognosis of diseases and for predicting response to drug treatment along with designing vitro diagnostics tests which cover a broad range of clinical needs.
Contact Information
Website
Formerly Known As
Medplant Genetics
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Office
- Ibaizabal Bidea, Edificio 504
- Parque Tecnológico de Bizkaia
- 48160 Derio
- Spain
+34 944 00 00 00
Progenika Biopharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Progenika Biopharma‘s full profile, request access.
Request a free trialProgenika Biopharma Executive Team (4)
Progenika Biopharma Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 | 22-Oct-2018 | 00000 00000 00 | 00.000 | Biotechnology | |
| 0000000000 | 01-Jan-2015 | 000000000000000000 | Diagnostic Equipment | ||
| Mecwins | Early Stage VC | Biotechnology |